Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
boston
boston blog main
boston top stories
clinical trials
national top stories
new york blog main
startups
new york top stories
blackstone group
david goldstein
depression
epilepsy
essential tremor
kiran reddy
major depressive disorder
perimenopausal depression
praxis precision medicines
san francisco blog main
san francisco top stories
steven petrou
third rock ventures
vc
adeno-associated virus
aligos therapeutics
alnylam
antisense oligonucleotide
arena pharmaceuticals
artie suckow
azacitidine
baker brothers life sciences
benzodiazepine
benzodiazepines
beta-thalassemia
biogen
biotech ipos
blackstone life sciences
blepharitis
What
drugs
5
×
medicines
5
×
new
research
aims
emerged
praxis
precision
therapeutics
way
adding
advance
ago
aiming
approach
backed
balance
based
biologics
biotech
biotechs
build
called
cause
central
ceo
cns
considered
debuts
decibel
deliver
developing
diseases
disorder
dtx
epigenetic
epigenetics
epilepsy
field
flagship’s
Language
unset
Current search:
xconomy.com
×
drugs
×
medicines
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further